NCT00158795View on ClinicalTrials.gov

Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine

PHASE4CompletedINTERVENTIONAL

Enrollment

454

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Haemophilus Influenzae Type b Disease

Interventions

BIOLOGICAL

Haemophilus Influenza type b vaccine

Trial Locations (1)

530021

GSK Investigational Site, Nanning

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY